SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $77,000 | -30.6% | 321,218 | +1.7% | 0.00% | – |
Q4 2015 | $111,000 | -79.7% | 315,918 | +0.4% | 0.00% | -100.0% |
Q3 2015 | $547,000 | -23.7% | 314,654 | -2.2% | 0.00% | 0.0% |
Q2 2015 | $717,000 | +93.3% | 321,591 | +68.2% | 0.00% | – |
Q1 2015 | $371,000 | -26.1% | 191,166 | +0.8% | 0.00% | -100.0% |
Q4 2014 | $502,000 | -11.3% | 189,568 | +0.8% | 0.00% | 0.0% |
Q3 2014 | $566,000 | -17.1% | 188,113 | +12.7% | 0.00% | 0.0% |
Q2 2014 | $683,000 | +13.1% | 166,938 | +19.2% | 0.00% | 0.0% |
Q1 2014 | $604,000 | -14.8% | 140,099 | +3.5% | 0.00% | 0.0% |
Q4 2013 | $709,000 | -2.9% | 135,335 | +17.0% | 0.00% | 0.0% |
Q3 2013 | $730,000 | +34.4% | 115,657 | +6.4% | 0.00% | 0.0% |
Q2 2013 | $543,000 | – | 108,746 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |